메뉴 건너뛰기





Volumn 14, Issue 12, 2013, Pages 1433-1443

Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells.

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL PRODUCT; IMMUNOGLOBULIN; INTEGRIN; INTEGRIN ALPHA4BETA7; MADCAM1 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; MUCOPROTEIN; VEDOLIZUMAB;

EID: 84897070797     PISSN: None     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/13894501113146660206     Document Type: Review
Times cited : (55)

References (0)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.